U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H8N2
Molecular Weight 120.1518
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENZAMIDINE

SMILES

NC(=N)C1=CC=CC=C1

InChI

InChIKey=PXXJHWLDUBFPOL-UHFFFAOYSA-N
InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)

HIDE SMILES / InChI

Molecular Formula C7H8N2
Molecular Weight 120.1518
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Crystal structures of QacR-diamidine complexes reveal additional multidrug-binding modes and a novel mechanism of drug charge neutralization.
2004-04-02
Collagen degradation by host-derived enzymes during aging.
2004-03
Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
2004-02-15
Understanding protein-ligand interactions: the price of protein flexibility.
2004-01-30
Protein interaction networks by proteome peptide scanning.
2004-01
Cloning and characterization of a transmembrane-type serine protease from rat kidney, a new sodium channel activator.
2003-12-13
Characterization of a trypsin-like serine protease of activated B cells mediating the cleavage of surface proteins.
2003-12-05
Synthesis of L-ascorbic acid in the phloem.
2003-11-24
[Preparation of high-purity and safe autologous plasmin and its clinical application].
2003-11
Multinuclear magnetic resonance and theoretical calculations in the study of structure and tautomerism of some 2-amino-N'-(aryl)-benzamidines.
2003-11
Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions.
2003-10-18
Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants.
2003-10-09
CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors.
2003-10-06
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
2003-09-01
Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
2003-09
Molecular cloning of trypsin-like cDNAs and comparison of proteinase activities in the salivary glands and gut of the tarnished plant bug Lygus lineolaris (Heteroptera: Miridae).
2003-09
[Purification and characterization of the fibrinolytic enzyme from Agkistrodon halys halys venom].
2003-08-15
Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
2003-08-14
Novel oxidative alpha-tosyloxylation of alcohols with iodosylbenzene and p-toluenesulfonic acid and its synthetic use for direct preparation of heteroaromatics.
2003-08-08
Engineering the primary substrate specificity of Streptomyces griseus trypsin.
2003-08-05
Design and synthesis of highly constrained factor Xa inhibitors: amidine-substituted bis(benzoyl)--diazepan-2-ones and bis(benzylidene)-bis(gem-dimethyl)cycloketones.
2003-08-05
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.
2003-06-16
Characterisation of integrin-linked kinase signalling in sporadic human colon cancer.
2003-06-02
Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors.
2003-06-01
Discovery of 3-amino-4-chlorophenyl P1 as a novel and potent benzamidine mimic via solid-phase synthesis of an isoxazoline library.
2003-05-19
Rational design, synthesis, and structure-activity relationships of novel factor Xa inhibitors: (2-substituted-4-amidinophenyl)pyruvic and -propionic acids.
2003-05-08
A role for BRCA1 in sporadic breast cancer.
2003-04-22
Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system.
2003-04-08
Identification and partial characterization of two inducible gelatin-cleavage activities localized to the sea urchin extraembryonic matrix, the hyaline layer.
2003-04-07
Purification, properties and substrate specificity of a digestive trypsin from Periplaneta americana (Dictyoptera) adults.
2003-04
Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors.
2003-03-24
Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket.
2003-02-27
Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.
2003-02-10
Nonbenzamidine tetrazole derivatives as factor Xa inhibitors.
2003-02-10
A novel influenza A virus activating enzyme from porcine lung: purification and characterization.
2003-02
Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity.
2003-01-31
Structure and activity of human pancreasin, a novel tryptic serine peptidase expressed primarily by the pancreas.
2003-01-31
Disruption of vitellogenin gene function in adult honeybees by intra-abdominal injection of double-stranded RNA.
2003-01-20
Purification and partial characterization of feline classical pancreatic lipase.
2003-01
Inhibitors of benzamidine type influence the virulence properties of Porphyromonas gingivalis strains.
2003
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
2003
The effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cells.
2002-12-16
Pattern recognition and massively distributed computing.
2002-12
Inhibition of arginine gingipains (RgpB and HRgpA) with benzamidine inhibitors: zinc increases inhibitory potency.
2002-11-20
Thrombin inhibition by novel benzamidine derivatives: a free-energy perturbation study.
2002-11-07
Identification, characterization, and cloning of an immunoglobulin degrading enzyme in the cat flea, Ctenocephalides felis.
2002-11
Mutant K-ras oncogene regulates steroidogenesis of normal human adrenocortical cells by the RAF-MEK-MAPK pathway.
2002-10-21
Aggregation and retention of human urokinase type plasminogen activator in the yeast endoplasmic reticulum.
2002-10-07
The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator.
2002-10-02
Development and validation of a capillary electrophoresis method for ximelagatran assay and related substance determination in drug substance and tablets.
2002-01-15
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:11:03 GMT 2025
Edited
by admin
on Mon Mar 31 19:11:03 GMT 2025
Record UNII
KUE3ZY3J1F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-243704
Preferred Name English
BENZAMIDINE
Systematic Name English
BENZENECARBOXIMIDAMIDE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID8045012
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
CAS
618-39-3
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
FDA UNII
KUE3ZY3J1F
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
DRUG BANK
DB03127
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
ECHA (EC/EINECS)
210-546-3
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
CHEBI
41033
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
NSC
243704
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
WIKIPEDIA
BENZAMIDINE
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
PUBCHEM
2332
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
MESH
C032157
Created by admin on Mon Mar 31 19:11:03 GMT 2025 , Edited by admin on Mon Mar 31 19:11:03 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
ANTAGONIST
Kb
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
BINDING
Ki
Related Record Type Details
PARENT -> METABOLITE INACTIVE